Analytical Data
-
Gene name
DBP
- Application
-
Alternative Names
DBP;D site-binding Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P03264
-
Expression Region
174-529aa
-
AA Sequence
SLPIVSAWEKGMEAARALMDKYHVDNDLKANFKLLPDQVEALAAVCKTWLNEEHRGLQLTFTSNKTFVTMMGRFLQAYLQSFAEVTYKHHEPTGCALWLHRCAEIEGELKCLHGSIMINKEHVIEMDVTSENGQRALKEQSSKAKIVKNRWGRNVVQISNTDARCCVHDAACPANQFSGKSCGMFFSEGAKAQVAFKQIKAFMQALYPNAQTGHGHLLMPLRCECNSKPGHAPFLGRQLPKLTPFALSNAEDLDADLISDKSVLASVHHPALIVFQCCNPVYRNSRAQGGGPNCDFKISAPDLLNALVMVRSLWSENFTELPRMVVPEFKWSTKHQYRNVSLPVAHSDARQNPFDF
-
Molecular Weight
45.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DBP (D-box binding protein) is a key regulator in various physiological processes, including cell proliferation, differentiation, and metabolic regulation. This protein functions as a transcription factor, binding to specific DNA sequences to modulate the expression of target genes. Research on DBP has gained prominence due to its involvement in circadian rhythms and its role in certain diseases, such as cancer and metabolic disorders. Understanding the structural and functional properties of DBP is vital for elucidating its mechanisms of action and regulatory pathways. Recent advancements in recombinant DNA technology have enabled the production of DBP in a controlled manner, facilitating detailed studies of its interactions with other biomolecules and its influence on gene expression. Moreover, reconstituted DBP offers potential therapeutic applications, as targeting its activity may lead to novel treatments for circadian-related disorders and other pathologies. Overall, the recombinant study of DBP provides crucial insights into its biological significance and opens up avenues for innovative research and clinical applications.











